Global Prefilled Syringes Market to Show One-Digit Growth, Expects Roots Analysis in New Report Available at MarketPublishers.com
30 Jan 2017 • by Natalie Aster
LONDON – At present, there are over 100 vaccines and drugs are available in prefilled syringes across various therapeutic classes. Some of the most popular drugs are Pegasys®, Enbrel®, Rebif®, and more.
Approximately 70 drugs in the prefilled syringe format are currently in the clinical development stage.
The rise of biologics has become the number one factor driving growth of the marketplace. Still, some biologics are about to get off patent in the offing. Developers of biosimilars will compete with each other for the same drug, and they may use prefilled syringes as a major differentiator.
Pipeline drugs are set to fuel the market’s evolution in the long term. Technological advances and a rise in the adoption will be other driving forces.
The integration of prefilled syringes with advanced delivery systems (e.g. autoinjectors) is one more factor that favors the growth.
This market boasts a high level of consolidation. It is ruled by such manufacturers as Nuova Ompi, SCHOTT, Becton Dickinson, and more.
A number of regional players have surfaced. In China, for instance, local players have an installed yearly production capacity of 150 million units.
The global market is expected to grow at a CAGR of just under 4% over the period 2016-2026. North America and the EU are the largest players at a regional level. Still, the highest growth is set to occur in other regions.
New research report “Prefilled Syringes Market (4th Edition), 2017 - 2026” drawn up by Roots Analysis offers an insightful guide to the worldwide market for prefilled syringes. The study starts with a detailed introduction to this marketplace.
It proceeds with an in-depth overview of the market as well as its segments. The report delves deep into the regulatory environment and scrutinizes growth drivers. The research study sheds light on products that are currently available in prefilled syringes.
It also covers likely candidates for the syringes. The research report sheds light on leading manufacturers as well as other major players. The study comprises details on major developments and contains case studies. Future outlook for the marketplace is on hand in the report, too.
More new studies by Roots Analysis are available at its page.